Key Takeaways Clinical trials produce better research findings when participants reflect the people who will use the treatment. The Food and Drug Omnibus Reform Act of 2022 requires sponsors of certain studies to submit a Diversity Action Plan with enrollment goals to the FDA. [...]

Sponsors gravitate toward large clinical trial site networks for a natural reason: they're an easy way to scale studies fast. Networks are a smart foundation for a lot of studies, but they work best alongside something else.Independent sitesbring a different kind of value:[...]

Clinical trial delays happen for all kinds of reasons. The causes vary. The results, almost always, do not: frustration and a budget that keeps climbing. The numbers tell the story plainly. Delays cost sponsors between$40,000 per day in direct operational expenses and anywhere[...]

Clinical trials depend on the ability to connect the right patients with the right studies. Yet across the research industry, identifying eligible participants is becoming increasingly complex. That’s whyimproving patient access to clinical trials is a top priority for clinical[...]

Sponsors today have more tools than ever to support clinical trial recruitment strategies. Digital campaigns can reach highly specific audiences. Social platforms increase visibility. Hybrid models reduce participation burden and expand geographic flexibility. Yet patient[...]